Cross-Sector entity

The Lancet

Product
6.8

World Health Organization is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. The 116-day window averages about 0.2 stories each week. The busiest single day carried 2. clinical-trial accounts for 1 of the 4 tracked stories, while 3 other categories carry the remainder.

4 verified stories tracked

Last mentioned: Mar 17, 2026

Entity pulse

Recent coverage · The Lancet

4 stories
6.8 avg impact
25% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 25 percentage points.

  • 25% positive
  • 25% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about The Lancet

World Health Organization is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. The 116-day window averages about 0.2 stories each week. The busiest single day carried 2. clinical-trial accounts for 1 of the 4 tracked stories, while 3 other categories carry the remainder. We currently track 4 Cross-Sector stories that mention The Lancet, published between March 7, 2026 and June 30, 2026. Each carries 2 original sources on average.

Stories tracked
4
Per week
0.2
Sources per story
2

Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering The Lancet. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Lancet Series on Postpartum Haemorrhage Published

    The Lancet releases a three-part series consolidating evidence on PPH, the E-MOTIVE strategy, and implementation guidance, with a special emphasis on high-burden countries like India.

  2. Mental Health Focus

    Cannabis clinics see a surge in patients seeking treatment for anxiety and PTSD.

  3. Clinical Findings Released

    The Lancet publishes data showing no significant benefit over placebo for psychiatric conditions.

  4. Resilience Briefing

    Public health experts emphasize the role of antioxidants and lifestyle adjustments in climate adaptation.

  5. WHO Policy Update

    World Health Organization integrates climate-health resilience into its primary care guidelines.

  6. PM2.5 Study Release

    Major research links long-term wildfire smoke exposure to a 10% increase in stroke risk among elderly populations.

  7. Record Global Temperatures

    Hottest month on record triggers global health warnings regarding heat-induced cardiac arrest.

  8. E-MOTIVE Trial Published

    A large cluster-randomized trial across low- and middle-income countries demonstrates that objective blood-loss measurement with a calibrated drape plus a bundled treatment package significantly reduces PPH-related severe morbidity and mortality.

  9. Legalization Milestone

    Australia legalizes medicinal cannabis at the federal level, sparking industry growth.

Stories mentioning The Lancet 4

Healthcare medical devices Strongly positive 8

Simple Drape Bundle Could Cut 38% of Maternal PPH Deaths: Lancet Series

The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.

2 sources

Source: Kirti Pandey (in) · Kirti Pandey (in)

Biotech clinical trial Negative 7

Lancet Study Challenges Efficacy of Medicinal Cannabis for Mental Health

A comprehensive study published in The Lancet concludes that medicinal cannabis is largely ineffective for treating anxiety, depression, and PTSD. These findings challenge the rapidly growing global market for cannabinoid-based mental health treatments and highlight a significant gap between patient perception and clinical evidence.

2 sources